Is there really any way that financial engineering could cure cancer? That was the argument that MIT’s great Andrew Lo made during a visit to London last week, and being an entrepreneurial finance professor he is now trying to bang the drum to get his idea off the ground. If he has his way, he will end up creating a $30bn cancer “super-fund” that will invest in 150 different anti-cancer projects.
It is if nothing else a fascinating idea. I wrote a Monday column on it, while the Economist’s Buttonwood (in real life a former Long View writer) blogged on it. Both of us came out broadly in favour. My video interview with Professor Lo appears here:
Virtually all of us as humans would like it to work. Does it actually stand a chance? More on that after the break. Read more